Vulvovaginal Candidiasis Treatment Market by Drug Class (Nystatin, Ketoconazole, Clotrimazole, Terconazole, Fluconazole, Terbinafine, Others), Route of Administration (Topical, Oral, Intravenous), Distribution Channel (Online Pharmacy, Hospital Pharmacy), and by Region - Global Forecast to 2022-2033

The vulvovaginal candidiasis treatment market size is estimated to be USD 997.76 million in 2022 and is expected to witness a CAGR of 4.85% during the forecast period 2023-2033. Rise in the incidence of disease, advancements in R&D, novel approvals, and drug launches are some of the factors contributing to the market growth. Furthermore, surge in hospital-acquired infections, rise in healthcare spending, and improvements in healthcare infrastructure are other factors supporting the market growth. However, lack of awareness regarding the disease is expected to hinder the growth.

Rise in the incidence of disease is expected to propel the market growth during the projected period. Increase in the number of people with diabetes and surge in the incidence of antibiotic resistance are both contributing to the disease’s rising incidence. Nearly 75% of females who report experience the disease at least once in their lifetime are now affected by the VVC infection that is on the rise in the world. An NCBI article states that 9% of women report recurrent VVC cases and that 10-20% of women worldwide are affected by complicated VVC.

Advancements in R&D, novel approvals, and drug launches is predicted to fuel the market growth during the forecast period. For instance, the oral medication VIVJOA was approved by the FDA in August 2022. The antifungal medicine VIVJOA from Mycovia Pharmaceuticals specifically targets and inhibits fungus CYP5. The FDA approved BREXAFEMME (Ibrexafungerp), a novel medicine from Scynexis, Inc. that is indicated to treat VVC, in June 2021. The growth of the industry is predicted to be spurred by all of these launches.

Segmentation

By Drug Class

The market is categorized into nystatin, ketoconazole, clotrimazole, terconazole, fluconazole, terbinafine, others. In 2022, the fluconazole segment accounted for the highest revenue share due to its high efficiency. The fungus that is causing the infection is eliminated by fluconazole. The medication kills the fungus by rupturing the cell membrane and allowing the insides to escape. This eliminates the infection and relieves the symptoms. The clotrimazole segment is anticipated to dominate the global market throughout the forecast period due to due to the high effectiveness and widespread use of the medicine clotrimazole. Clotrimazole, an antimycotic agent, was initially registered in Germany in 1973 under the trade name Canesten. Among the top brands used to treat vulvovaginal candidiasis is still Canesten. Later, there were soft capsules (soft ovules), internal vaginal cream, and external cream available. Different formulations are available in the market under various brand names, including Mycoderm-C, Abzorb, and Candid-V.

By Route of Administration

The market is categorized into topical, oral, and intravenous. In the global market, the oral segment accounted for the largest revenue share in 2022 owing to the common & practical route of administration for azoles, high absorption, and use for anti-fungal medications. The most often prescribed medication for both treatment and maintenance therapy is oral fluconazole. In cases of recurrent VVC, it is also useful when used as a short-term therapy. The FDA recently approved two oral dosage regimes of VIVJOA (oteseconazole) to lower recurrent VVC occurrences. The topical segment is anticipated to expand at a steady CAGR during the course of the study. The market demand is boosted by a significant supply of topical products, including over-the-counter and prescription formulations. Clotrimazole cream, Miconazole cream, and Tioconazole ointment are available over-the-counter (OTC), although Butoconazole cream and Terconazole cream require a prescription. Additionally, econazole and nystatin, which have been available on the market for more than 30 years, are recommended as topical antifungals. According to IDSA recommendations, topical antifungal medications should be used to treat mild VVC.

By Distribution Channel

The market is segmented into online pharmacy, hospital pharmacy, and retail pharmacy. In 2022, the retail pharmacy segment accounted for the largest revenue share owing to the fact that medication assistance is required for both short-term and long-term disease treatment, control, and management. Both prescription and over-the-counter (OTC) medications are available on the market, therefore pharmacists play a crucial role by advising patients and gaining their trust. Most medications can be obtained easily from retail pharmacies, especially while receiving care at home. All of these factors are anticipated to support the segment’s expansion. The online pharmacy distribution channel segment is anticipated to expand significantly during the projection period due to convenience and other advantages including home delivery.

Regional Markets

In 2022, North America region accounted for the highest revenue in the vulvovaginal candidiasis treatment market and is expected to maintain its dominance during the forecast period. This is attributed to the strict regulations, growing government support for enhancing healthcare infrastructure, and the presence of major market competitors in the area.

Competitor Insights

Some of the key players operating in the vulvovaginal candidiasis treatment market are Pfizer, Inc., Basilea Pharmaceutica Ltd., Bayer AG., Mycovia Pharmaceuticals, Inc., Cadila Pharmaceuticals, Astellas Pharma Inc., Grupo Ferrer International S.A., Scynexis, Inc., and Bristol-Myers Squibb Company.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

  • For instance, in August 2022, the FDA approved Mycovia Pharmaceuticals’ VIVJOA, which was already authorized in some European, Asian, and Latin American nations, for the treatment of recurrent VVC in the United States.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including drug class, route of administration, and distribution channel from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 997.76 Million
CAGR
  • 4.85%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Drug Class
  • Route of Administration
  • Distribution Channel
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Vulvovaginal Candidiasis Treatment Market Report 2022 – 2033

Drug Class (Revenue, USD Million), 2022 – 2033

  • Nystatin
  • Ketoconazole
  • Clotrimazole
  • Terconazole
  • Fluconazole
  • Terbinafine
  • Others

Route of Administration (Revenue, USD Million), 2022 – 2033

  • Topical
  • Oral
  • Intravenous

Distribution Channel (Revenue, USD Million), 2022 – 2033

  • Online Pharmacy
  • Hospital Pharmacy
  • Retail Pharmacy

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Vulvovaginal Candidiasis Treatment Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Route of Model
  1. Introduction: Vulvovaginal Candidiasis Treatment
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Vulvovaginal Candidiasis Treatment Market
  3. Market Analysis by Drug Class
    1. Nystatin
      1. Nystatin Market Forecast, 2022-2033(USD Million)
    2. Ketoconazole
      1. Ketoconazole Market Forecast, 2022-2033(USD Million)
    3. Clotrimazole
      1. Clotrimazole Market Forecast, 2022-2033(USD Million)
    4. Terconazole
      1. Terconazole Market Forecast, 2022-2033(USD Million)
    5. Fluconazole
      1. Fluconazole Market Forecast, 2022-2033(USD Million)
    6. Terbinafine
      1. Terbinafine Market Forecast, 2022-2033(USD Million)
    7. Others
      1. Others Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Route of Administration
    1. Topical
      1. Topical Market Forecast, 2022-2033(USD Million)
    2. Oral
      1. Oral Market Forecast, 2022-2033(USD Million)
    3. Intravenous
      1. Intravenous Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Distribution Channel
    1. Online Pharmacy
      1. Online Pharmacy Market Forecast, 2022-2033(USD Million)
    2. Hospital Pharmacy
      1. Hospital Pharmacy Market Forecast, 2022-2033(USD Million)
    3. Retail Pharmacy
      1. Retail Pharmacy Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends Analysis
  2. North America Vulvovaginal Candidiasis Treatment Market
    1. North America Vulvovaginal Candidiasis Treatment Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. S. Vulvovaginal Candidiasis Treatment Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. Canada Vulvovaginal Candidiasis Treatment Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Europe Vulvovaginal Candidiasis Treatment Market
    1. Europe Vulvovaginal Candidiasis Treatment Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Germany Vulvovaginal Candidiasis Treatment Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. UK Vulvovaginal Candidiasis Treatment Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. France Vulvovaginal Candidiasis Treatment Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. Spain Vulvovaginal Candidiasis Treatment Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              2. Italy Vulvovaginal Candidiasis Treatment Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                  2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                  3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                2. Rest of Europe Vulvovaginal Candidiasis Treatment Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                    2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                    3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Asia Pacific Vulvovaginal Candidiasis Treatment Market
    1. Asia Pacific Vulvovaginal Candidiasis Treatment Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Japan Vulvovaginal Candidiasis Treatment Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. China Vulvovaginal Candidiasis Treatment Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. India Vulvovaginal Candidiasis Treatment Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. South Korea Vulvovaginal Candidiasis Treatment Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              2. Australia Vulvovaginal Candidiasis Treatment Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                  2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                  3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                2. Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                    2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                    3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Latin America Vulvovaginal Candidiasis Treatment Market
    1. Latin America Vulvovaginal Candidiasis Treatment Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Brazil Vulvovaginal Candidiasis Treatment Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. Mexico Vulvovaginal Candidiasis Treatment Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. Argentina Vulvovaginal Candidiasis Treatment Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. Rest of Latin America Vulvovaginal Candidiasis Treatment Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. MEA Vulvovaginal Candidiasis Treatment Market
    1. MEA Vulvovaginal Candidiasis Treatment Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. GCC Vulvovaginal Candidiasis Treatment Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. South Africa Vulvovaginal Candidiasis Treatment Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. Rest of MEA Vulvovaginal Candidiasis Treatment Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              2. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Pfizer, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    2. Basilea Pharmaceutica Ltd.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    3. Bayer AG.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    4. Mycovia Pharmaceuticals, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    5. Cadila Pharmaceuticals
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    6. Astellas Pharma Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    7. Grupo Ferrer International S.A.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    8. Scynexis, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    9. Bristol-Myers Squibb Company
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    10. Company 10
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
  1. Conclusion
  2. Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.